Last reviewed · How we verify

NCT04021407

Laryngeal Mask Airway Versus Air Q Laryngeal Airway

Completed NA Last updated 16 July 2019
What this trial tests

NA trial testing LMA group in Airway Devices in 72 participants. Completed in 1 June 2019.

Timeline
1 April 2018
Primary endpoint
1 June 2019
1 June 2019

Quick facts

Lead sponsorMenoufia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment72
Start date1 April 2018
Primary completion1 June 2019
Estimated completion1 June 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 18 to 60, any sex, with Airway Devices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nowadays, supraglottic airway devices are simple and effective alternatives to endotracheal intubation. Both laryngeal mask airway LMA and air-Q airway are supraglottic airway devices that can be used to maintain and protect airways from aspiration of secretions and blood during DCR surgery. The present study was designed to compare standard LMA versus air Q as regards the sealing effect and aspiration of blood in DCR surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Airway Devices

Currently open trials in the same condition.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04021407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing